Table 4.
Group Variable (Mean ± SEM) |
GI (n = 10) | GII (n = 10) | GIII (n = 10) | GIV (n = 10) | GV (n = 10) |
---|---|---|---|---|---|
Body weight (gm) | 232.80 ± 8.84 | 229.50 ± 6.89 | 241.60 ± 8.47 | 230.50 ± 5.57 | 236.40 ± 4.39 |
Absolute testis weight (mg) | 131.50 ± 0.50 b | 106 ± 0.53 acde | 124.50 ± 2.72 be | 133.30 ± 3.47 b | 141.9 ± 1.96 bc |
Relative testis weight | 0.58 ± 0.04 b | 0.47 ±0.03 ade | 0.52 ± 0.02 | 0.58 ±0.01 b | 0.60 ±0.01 b |
GI: CTL, normal control, GII: GM, gentamycin induced testicular damage, GIII: PIO 5 (5 mg/kg/day) pioglitazone treated group, GIV: PIO 10 pioglitazone treated (10 mg/kg/day) and GV: PIO 20 pioglitazone treated (20 mg/kg/day). Values are expressed as mean ± SEM. (a) compared to control group (GI), (b) compared to GM treated group (GII), (c) compared to PIO 5 (GIII) group, (d) compared to PIO 10 (G IV) group, (e) compared to PIO 20 (GV) group.